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In a 3-year longitudinal study, we examined the relationship between the seasonal prevalence of antimicro-
bial-resistant (AR) Escherichia coli isolates from human wastewater and swine fecal samples and the following
risk factors: the host species, the production type (swine), the vocation (human swine workers, non-swine
workers, and slaughter plant workers), and the season, in a multisite, vertically integrated swine and human
population representative of a closed agri-food system. Human and swine E. coli (n  4,048 and 3,429,
respectively) isolates from wastewater and fecal samples were tested for antimicrobial susceptibility, using the
Sensititre broth microdilution system. There were significant (P < 0.05) differences among AR E. coli preva-
lence levels of (i) the host species, in which swine isolates were at higher risk for resistance to tetracycline,
kanamycin, ceftiofur, gentamicin, streptomycin, chloramphenicol, sulfisoxazole, and ampicillin; (ii) the swine
production group, in which purchased boars, nursery piglets, and breeding boars isolates had a higher risk of
resistance to streptomycin and tetracycline; and iii) the vocation cohorts, in which swine worker cohort isolates
exhibited lower sulfisoxazole and cefoxitin prevalence than the non-swine worker cohorts, while the slaughter
plant worker cohort isolates exhibited elevated cefoxitin prevalence compared to that of non-swine workers.
While a high variability was observed among seasonal samples over the 3-year period, no significant temporal
trends were apparent. There were significant differences in the prevalence levels of multidrug-resistant isolates
between host species, with swine at a higher risk of carrying multidrug-resistant strains than humans.
Considering vocation, slaughter plant workers were at higher risk of exhibiting multidrug-resistant E. coli than
non-swine workers.
The emergence, propagation, accumulation, and mainte-
nance of strains of antimicrobial-resistant (AR) pathogenic
bacteria have become a worldwide health concern in human
and veterinary medicine (1, 9, 19). The intensive therapeutic
uses and misuses of antimicrobial agents in humans and com-
panion animals, as well as their therapeutic, prophylactic, and
subtherapeutic uses for growth promotion in food animals,
have substantially increased selective pressures on both patho-
genic and commensal bacteria, thus favoring the propaga-
tion, accumulation, and maintenance of AR bacteria (8).
Many authors have attempted to link antimicrobial use in
food animal agriculture with an increased risk of AR bacteria
in humans (15, 18, 20). These authors have speculated that AR
bacteria in animals could transfer to human populations
through direct contact (e.g., occupational exposure) and
through indirect contact with animals (e.g., consumption of
contaminated food products of animal origin). However, those
studies have been based largely on historical data and cross-
sectional studies lacking a temporal component to establish
cause-effect relationships.
In several antimicrobial resistance studies, assessments of
human exposure to AR bacteria from animals and food prod-
ucts of animal origin, in relationship to resistance levels in
human populations, have lacked the control of several essen-
tial factors including (i) open study populations, with limited or
no control over the in- and out-migration of subjects (humans
or animals) in the study areas; (ii) human travel and trade in
animals and food products, which serve as a source for AR
bacteria that can be introduced into susceptible populations;
and (iii) lack of temporal components, as in cohort studies that
require follow-up with individual or groups of animal and
human subjects over a lengthy period of time (2, 4, 11, 12, 15,
16, 17).
The primary objective of this 3-year longitudinal study con-
ducted at multiple sites and with a vertically integrated swine
and human agri-food system, was to examine the relationship
between the prevalence of AR commensal Escherichia coli
isolates from human wastewater and swine fecal samples from
group-level cohorts of humans and swine and the following
potential risk factors: (i) host species (swine versus human),
(ii) swine production type (e.g., breeding/gestation, farrowing,
nursery, grower, or finisher pigs); (iii) human vocation (swine
workers, non-swine workers, and slaughter plant workers); (iv)
human consumers versus nonconsumers (and non-swine work-
ers); and (v) season.
MATERIALS AND METHODS
Study design. The agri-food system that we studied represented multisite
housing units consisting of vertically integrated populations of human workers
(and potential pork consumers) and swine. Humans were housed in 19 purpo-
sively chosen and geographical locations (units) across the state of Texas. Twelve
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of these units had colocated swine operations. One location was colocated with
a swine slaughter facility.
Human population. The human population consisted of a total of approxi-
mately 39,000 male individuals distributed over the 19 unit locations. The age of
the male population within the study system ranged from 18 to 50 years old,
with the majority ranging between 30 and 49 years (3), and the average length of
stay for each individual across all locations was 4.5 years. Based on occupational
exposure (i.e., vocation) to swine and other factors, these populations were
classified as either swine workers, non-swine workers, swine slaughter plant
workers, or non-swine workers/nonconsumers. Swine workers, non-swine work-
ers, and swine slaughter plant workers potentially had the opportunity to con-
sume pork produced within the integrated system; therefore, only the non-swine
workers/nonconsumers did not have the opportunity to consume pork produced
within the system. There were 12 units where both swine workers and non-swine
workers resided, 6 units with only non-swine workers, and only 1 unit with a
swine slaughter plant facility. Greater than 90% of the human population con-
sisted of individuals with no potential for vocational exposure to swine. There
was limited movement of new residents into the system and limited movement
out of the system (the average duration of stay was 4.5 years or about 1.85%
turnover per month). There was also a non-swine worker/nonconsumer cohort
that resided outside the agri-food system (at some of the unit locations); this
cohort was sampled in order to more properly represent the general human
population as a “negative control” group.
Swine population. The swine population consisted of approximately 26,000 to
28,000 pigs in any given month, located across the 12 unit locations. The 12 swine
operations were composed of five farrow-to-finisher swine facilities and seven
grower-to-finisher facilities. There were occasional (i.e., roughly every 6 months)
movements of pigs into the system (purchased purebred and mixed breed boars).
These swine were received into a single quarantined swine operation, where pigs
were held for 4 weeks prior to moving to the farrow-finisher operations. In
addition, there were some outside gilts introduced into the system during the
study period. However, there was little or no movement out of the system, since
all the pigs were slaughtered and consumed within the system, except for very
minor numbers of slow-growing swine. The slaughtered swine flowed vertically
through farrow-to-finisher units (farrowing barns to the hot nursery, then on to
the cold nursery, the grower, and last to the finisher barns) or else from the cold
nursery to other stand-alone grower-finisher units and were then sent to slaugh-
ter, where pork products were processed and fed back to the human population
housed within the system. When pigs arrived at the slaughter plant, they were
lairaged in holding pens overnight before they were slaughtered the next day. For
the purpose of data analysis, the swine population was categorized into seven
production groups, as follows: (i) farrow-crated pigs (which included farrowing
sows and their piglets), (ii) nursery piglets (which included both hot- and cold-
nursery piglets), (iii) breeding/gestation females (which included breeding gilts,
pregnant sows, and gilts), (iv) breeding boars, (v) quarantined boars (purchased
boars held at the quarantine facility), (vi) grower-to-finisher pigs, and (vii)
slaughtered pigs (pigs at the holding pens).
Sampling scheme: human population. Multiple composite wastewater grab
samples (approximately 50 ml each) were collected from all 19 human unit
locations. These wastewater samples were sewage samples taken from sewer
holes known to drain lavatory facilities representative of the four different co-
horts of humans described above. The sewage wastewater systems (one at each
unit location) were closed; that is, they were not susceptible to a rain-water-
dilution effect due to surface water runoff during storms. The samples were
collected monthly over a period of 36 months (February 2004 to January 2007)
by trained personnel at each unit location. The mean temperature across the
study units over the 3 years was 19.7°C, ranging between 5.5 and 29.8°C. Typi-
cally, at each unit with a swine operation, three swine-worker wastewater samples
(potential pork consumers), three non-swine worker (including both potential
pork consumers as well as known nonconsumers) wastewater samples, and one
mixed influent (draining from all the groups) sample were collected. At those
units without a swine operation, four wastewater samples: three non-swine
worker (both potential pork consumers and nonconsumers) samples draining
from sewer holes and one mixed influent sample were collected. At the single
unit with a slaughter plant, seven wastewater samples were collected, represent-
ing three non-worker sewer holes (potential pork consumers), three slaughter
plant worker sewer holes (potential pork consumers), and one mixed influent.
The specific sampling locations were chosen to differentiate among the occupa-
tional and consumer group-level cohorts. Typically, the number of wastewater
samples collected per month was 116. The numbers of wastewater samples
collected over the 3-year period were as follows: 2,837 samples from the units
with swine operations, 802 samples from the units without swine operations, and
182 samples from the unit with a slaughter plant. Sample pickup and shipping
from each unit were performed by a privately licensed and contracted laboratory
(samples were first refrigerated immediately following collection and then trans-
ported on ice overnight to the USDA-ARS-Southern Plains Agricultural Re-
search Center [USDA-ARS-SPARC], College Station, TX) for further analysis.
This contracted laboratory also collected and processed wastewater samples for
the facilities’ environmental regulatory purposes.
Swine population. Composite fresh fecal floor samples (approximately 50 g
each) and barn wash/prelagoon influent samples (approximately 50 ml) were
collected from the 12 swine operation pens and the slaughter plant holding pens
by a swine specialist veterinarian. Those samples were likewise collected monthly
for a period of 36 months (January 2004 to December 2006). Samples were kept
at 4°C overnight until they were shipped to the USDA-ARS-SPARC laboratory.
Swine pens at every unit containing each of the production stages of swine were
sampled at least once every 3 months. Each composite fecal sample (50 g) was
composed of equal proportions of fecal pats randomly sampled from multiple
pens. Barn wash/prelagoon samples were obtained from collection points that
drained the pens. Furthermore, composite fecal samples from the slaughter plant
holding pens, the kill floor effluent, and the pork trim samples from the slaughter
plant unit also were collected monthly. Approximately one-third of the total pork
consumed by the human population was from imported pork trim that was fully
processed into breakfast sausage (personal communication with the swine spe-
cialist veterinarian). Grab samples were collected from each of these imports
(pork trim) and evaluated for AR E. coli isolates. Typically, the total number
(from all locations) of composite fecal samples per month was 140, and the
number of barn wash/prelagoon influent samples was 35. The number of monthly
swine samples was somewhat variable over the study period due to changes in the
number of pigs at different production stages in the operations over the study
period.
Phenotypic analysis of antimicrobial-resistant E. coli: microbiological isola-
tion of E. coli isolates. When samples arrived at the laboratory, 5 aliquots of each
of the human and swine samples was frozen at72°C; three with glycerol, at a ratio
of 3:1 (sample:glycerol), and two without glycerol, for later analysis. At the time of
microbiological analysis, frozen human wastewater samples (with glycerol) were
thawed completely and vortexed or mixed with a sterile loop, and then a 1-ml aliquot
of wastewater sample was added to 9 ml of tryptic soy broth (Becton Dickinson and
Company, Sparks, MD) for enrichment. This mixture was then incubated for 18 h at
37°C, streaked onto a selective medium of CHROMagar E. coli (DRG Interna-
tional, Mountainside, NJ) and incubated further at 37°C for 18 to 24 h. No enrich-
ment step was used when thawed swine fecal samples were cultured (i.e., these were
streaked directly onto CHROMagar). For pork trim, approximately 5 g was dis-
sected from the pork trim sample, mixed for 1 min in a stomacher with peptone
water (10 ml), and then streaked with a sterile loop onto CHROMagar as described
above.
A single typical E. coli colony (blue color with a smooth surface) was randomly
selected from the CHROMagar plate, streaked onto a blood agar plate, and then
incubated (18 h, 37°C). E. coli isolates on the blood agar were used for antimi-
crobial susceptibility testing (see below), and the remaining E. coli isolates were
transferred onto glycerol-coated beads (Key Scientific, Round Rock, TX) and
stored at 72°C for future retrospective analyses. Based on a pilot study for this
research project (13), CHROMagar E. coli-selective medium was noted to be
highly specific and yielded 98% E. coli colonies. Furthermore, a biochemical
test strip (API 20E; BioMe´rieux, Inc.) was used regularly as a quality control to
confirm the isolated bacteria were E. coli.
Determination of antimicrobial susceptibility for E. coli isolates. An E. coli
isolate was picked from the blood agar culture as described above, and the MIC
was determined for different antimicrobial agents by broth microdilution follow-
ing CLSI (formerly NCCLS) standards (10). Antimicrobial susceptibility testing
was performed with a Sensititre automated system, according to the manufac-
turer’s instructions (Trek Diagnostic Systems, Cleveland, OH), using custom
panels designed by the National Antimicrobial Resistance Monitoring System
(NARMS) (7). The MICs for the E. coli isolates tested were determined to be
either resistant or susceptible based on CLSI breakpoints or else based on
NARMS committee consensus, where no CLSI breakpoint existed (10). Inter-
mediate MIC results were reclassified as susceptible. To assess the variability in
the number of different resistant phenotypes in a sample, five E. coli colonies
were randomly selected from human and swine samples during 1 month only
(February 2005). The mean number of different phenotypes per plate for human
and swine for that month were 2.25 and 1.98 (out of 5), respectively, and the
median was 2 for both human and swine. The antimicrobial agents used in the
NARMS (7) panels and their breakpoints are shown in Table 1. The MIC ranges
included in Table 1 represent the antimicrobial agent dilutions for the NARMS
gram-negative bacteria panel; hence, the dilutions and breakpoints used in this
study. Quality control organisms from the American Type Culture Collection
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(ATCC; Manassas, VA), E. coli strains 25922 and 35218, Enterococcus faecalis
29212, and Pseudomonas aeruginosa 27853, were evaluated with approximately
every 200 NARMS custom panels (or, when a new batch, as determined by serial
number, of plates was begun); this quality control check was not necessarily made
on a daily basis. Based on our pilot study (13), the consistency of the antimicro-
bial susceptibility quality control testing was very high.
Sample phenotypic analysis scheme. Samples were analyzed on a quarterly
basis over the 3-year study period. All human and swine samples collected during
the first 12 months of the study were phenotypically analyzed. These data were
later collapsed into four seasons (or yearly quarters) based on (i) winter (Feb-
ruary to April), (ii) spring (May to July), (iii) summer (August to October), and
(iv) autumn (November to January). Thereafter, only quarterly phenotypic anal-
ysis was performed with the other 24 months of sampling. Quarterly sampling
and analysis were conducted because the highest variability observed was be-
tween seasons rather than between months within a season, based on the first 12
months of data analysis.
Statistical analysis: descriptive statistics. The 15 antimicrobial-resistant E.
coli outcomes (binary), as well as the multidrug resistance totals (multinomial),
were cross-tabulated with each of the risk factor categories: host species (swine
versus human), swine production type (e.g., breeding/gestation, breeding boars,
farrowing, nursery, grower-finisher, isolation boar, slaughter holding pens), hu-
man vocation (swine worker, slaughter plant workers, and non-swine workers),
human consumer versus nonconsumer, and season and year. Initially, the pro-
portion of bacterial isolates resistant to each of the antimicrobial agents was
compared across the levels of each risk factor, using either a two-sided 2-by-2
Fisher’s exact test or 2-by-n likelihood ratio chi-square test, as appropriate, with
STATA software version 9.2 (Stata Corp., College Station, TX). Multidrug
resistance was assessed for each risk factor as the sum of resistance (out of 15
agents, the upper [6] categories were collapsed) across all isolates, using an m 
n likelihood ratio chi-square test.
Multivariable analysis of risk factors for E. coli resistance to individual
antimicrobial agents. The association between each of the individual AR E. coli
phenotypes and the risk factors in the study was assessed using a generalized
linear model, with binomial error distribution and logit link function and ad-
justed for dependency within each unit location, using a generalized estimated
equation (GEE) in STATA version 9.2 software.
Multivariable analysis of risk factors for E. coli resistance to multiple anti-
microbial agents. The ordinal response (multidrug resistance from 0 to 6) of E.
coli phenotypes in relation to the risk factors was assessed by using a generalized
linear model model, with a multinomial distribution and a cumulative logit link
function and adjusted for dependency using GEE within each unit location in
SAS version 9.1 software (PROC GENMOD; SAS Institute, Inc., Cary, NC).
Multidrug resistance outcomes 6 were collapsed with response number 6
(called 6) because of the rare resistance phenotypes with very sparsely popu-
lated cells for some the outcomes.
Multivariate analysis (accounting for dependence among multiple binary out-
comes). The multiple binary AR outcomes (n  15) for E. coli isolates were
simultaneously assessed in relation to the risk factors, using a GEE model fitted
in a multivariate model, using a SAS software macro to adjust for dependence
among the isolate resistance phenotypes (i.e., pharmacologic and biological or
genetic dependence) and dependence within a unit location. Pharmacologic
dependence can arise since multiple AR outcomes reflect similar classes of
pharmaceuticals on the NARMS panel (e.g., cephalosporins such as cefoxitin,
ceftiofur, and ceftriaxone). Genetic (biological) dependence might arise when
genes that code for multiple AR outcomes are colocated on the same bacterial
genetic element (e.g., on a plasmid). This SAS macro was adapted from Shelton
et al. (14) and modified to perform the analysis of our data. The antimicrobial
agent odds ratios for AR E. coli isolates (unadjusted versus adjusted for depen-
dence among resistance phenotypes) were examined for (i) host species (swine
versus human [referent]) and (ii) human swine workers, slaughter plant workers,
non-swine workers/nonconsumers, isolation boars, breeding boars, farrowing
sows and piglets, breeding/gestation females, grower-finisher pigs, and nursery
pigs compared to that of the non-swine worker cohort (the referent).
TABLE 1. Tabulated ranges of dilutions and breakpointsa
Antimicrobial agent Range(s) Breakpoint(s)
Amikacin 0.5–64 64
Ampicillin 1–32 32
Amoxicillin-clavulanic acid 1/0.5–32/16 32/16
Cefoxitin 0.5–32 32
Ceftiofur 0.12–8 8
Ceftriaxone 1–64 64
Chloramphenicol 2–32 32
Ciprofloxacin 0.015–4 4
Gentamicin 0.25–16 16
Kanamycin 8–64 64
Nalidixic acid 0.5–32 32
Streptomycin 32–64 64
Sulfisoxazoleb 16–512 512
Tetracycline 4–32 16
Trimethoprim-sulfamethoxazole 0.12–4 4
a Values show tabulated ranges and breakpoints for the determination of E.
coli resistance to 15 antimicrobial agents, using a broth microdilution method
(Sensititre; TREK Diagnostic Systems, Inc., Cleveland, OH) on the NARMS
gram-negative bacteria panel.
b Sulfisoxazole was added to the new NARMS 2003 panel, and sulfamethox-
azole and cephalothin antimicrobial agents were dropped from its predecessor.
Sulfisoxazole had the same cut points as sulfamethoxazole on the previous
NARMS panel.
TABLE 2. Comparison of phenotypic resistance of commensal
enteric E. coli isolates sampled across human vocation groups,
swine production groups, and seasonsa
Host
speciesb Antimicrobial agent OR (P value)
c
Likelihood ratio
chi-square test
P valued
Swine Amikacin 2.59 (0.34) 0.154
Human 0.923
Swine Amoxicillin-clavulanic
acid
0.72 (0.047) 0.001
Human 0.146
Swine Ampicillin 1.22 (0.004) 0.001
Human 0.001
Swine Cefoxitin 0.62 (0.006) 0.001
Human 0.001
Swine Ceftiofur 5.56 (0.001) 0.001
Human 0.035
Swine Ceftriaxone 1.08 (0.99) 0.761
Human 0.923
Swine Chloramphenicol 2.02 (0.001) 0.001
Human 0.015
Swine Ciprofloxacin 0.19 (0.004) 0.976
Human 0.001
Swine Gentamicin 3.65 (0.001) 0.001
Human 0.005
Swine Kanamycin 9.41 (0.001) 0.001
Human 0.001
Swine Nalidixic acid 0.27 (0.001) 0.555
Human 0.001
Swine Streptomycin 3.52 (0.001) 0.001
Human 0.001
Swine Sulfisoxazole 2.40 (0.001) 0.001
Human 0.001
Swine Tetracycline 18.78 (0.001) 0.001
Human 0.001
Swine Trimethoprim-
sulfamethoxazole
0.15 (0.001) 0.074
Human 0.006
a The odds ratios (ORs) and P values, as well as the likelihood ratio P values,
for the proportion of E. coli isolates are presented and contrasted by host species.
Isolates are compared across all human vocation cohorts, swine production
groups, and seasons.
b Host species: swine, n  3,429; human, n  4,048.
c Odds ratio values present a comparison of the odds of prevalence for each
phenotype of antimicrobial resistance in swine versus that of human E. coli
isolates. P values are adjusted for the dependence of host species isolate response
within each unit location by using the generalized estimating equation (GEE)
statistic (STATA version 9.2 software, College Station, TX).
d P values are based on a likelihood ratio (2 test) of the differences in risk
across all units that were sampled. These data are presented and analyzed by host
species.
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RESULTS
Descriptive statistics. There were 7,477 (4,048 human and
3,429 swine) commensal E. coli isolates collected from the
wastewater and fecal matter samples over the 3-year study
period. Due to occasional scheduling conflicts, not all units
were sampled for wastewater collection every month. The 15
antimicrobial resistance outcomes (binary, susceptible or resis-
tant) for E. coli isolates were cross-tabulated by host species
(Table 2). The individual antimicrobial resistance E. coli phe-
notypes cross-tabulated by human vocation cohort (i.e., the
non-swine workers/nonconsumers, swine workers, non-swine
workers, influent mixture, and slaughter plant workers), are
shown in Table 3. The individual phenotypes cross-tabulated
by swine production group (i.e., slaughter plant holding pens
[slaughtered pigs], breeding boars, isolation/quarantined
boars, breeding sows, farrowing sows and piglets, growers and
finishers, and nursery piglets) are shown in Table 4. There were
12 E. coli bacterial strains isolated from the 160 pork trim
samples (7.5%), 11 of which were resistant to at least one
antimicrobial agent. Among those isolates, the total frequency
of multidrug-resistant phenotypes was as follows: pansuscep-
tible, n  1; single-agent-resistant isolate, n  4; and resistant
to three antimicrobial agents, n  7; with the most common
phenotypes of resistance to tetracycline and ampicillin-strep-
TABLE 3. Phenotypic resistance of commensal E. coli isolates sampled across human vocation groupsa
Antimicrobial
No. of E. coli isolates sampled by human vocation group (% of total)
P valuebNon-swine workers/
nonconsumers
(n  528)
Swine workers
(n  1,131)
Non-swine workers
(n  1,675)
Slaughter plant
workers (n  307)
Influent (mixed
isolates) (n  252)
Amikacin 0 (0.0) 0 (0.0) 2 (0.1) 0 (0.0) 0 (0.0) 0.497
Amoxicillin-clavulanic acid 29 (5.5) 22 (2.0) 41 (2.5) 12 (3.9) 5 (2.0) 0.002
Ampicillin 135 (25.6) 152 (13.4) 245 (14.6) 49 (16.0) 42 (16.7) 0.001
Cefoxitin 34 (6.4) 17 (1.5) 45 (2.7) 16 (5.2) 6 (2.4) 0.001
Ceftiofur 0 (0.0) 4 (0.4) 7 (0.4) 3 (1.0) 0 (0.0) 0.497
Ceftriaxone 0 (0.0) 0 (0.0) 2 (0.1) 0 (0.0) 0 (0.0) 0.092
Chloramphenicol 9 (1.7) 24 (2.1) 27 (1.6) 2 (0.7) 2 (0.8) 0.258
Ciprofloxacin 10 (1.9) 8 (0.7) 13 (0.8) 0 (0.0) 0 (0.0) 0.005
Gentamicin 0 (0.0) 6 (0.5) 9 (0.5) 5 (1.6) 0 (0.0) 0.012
Kanamycin 16 (3.0) 12 (1.1) 20 (1.2) 11 (3.6) 0 (0.0) 0.001
Nalidixic acid 24 (4.6) 54 (4.8) 94 (5.6) 1 (0.3) 14 (5.6) 0.001
Streptomycin 55 (10.4) 100 (8.8) 141 (8.4) 38 (12.4) 25 (9.9) 0.209
Sulfisoxazole 67 (12.7) 114 (10.1) 224 (13.4) 42 (13.7) 31 (12.3) 0.099
Tetracycline 98 (18.6) 231 (20.4) 300 (18.0) 102 (33.2) 57 (22.6) 0.001
Trimethoprim-sulfamethoxazole 45 (8.5) 74 (6.5) 125 (7.5) 33 (10.8) 13 (5.2) 0.069
a Phenotypic resistance of commensal E. coli isolates from human wastewater samples (n  3,893 isolates, with vocation cohorts identified). Frequencies and
proportions are contrasted with human vocation cohorts across all unit locations and seasons.
b P values are based on a likelihood ratio chi-square test of the differences in risk between human vocation cohorts. These P values are not adjusted for the
dependence of responses within unit locations.
TABLE 4. Phenotypic resistance of commensal E. coli isolates sampled from swine production groupsa
Antimicrobial agent
No. of E. coli isolates sampled by swine production group (% of total)
P valuebSlaughter
holding
pigs (n  72)
Breeding boars
(n  195)
Quarantined
boars
(n  331)
Breeding/gestation
females (n  131)
Farrowing sows
and piglets
(n  755)
Grower and
finisher pigs
(n  1,576)
Nursery piglets
(n  368)
Amikacin 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 1 (0.1) 3 (0.2) 0 (0.0) 0.784
Amoxicillin-clavulanic acid 1 (1.4) 1 (0.5) 6 (1.8) 1 (0.8) 30 (4.0) 13 (0.8) 25 (6.8) 0.001
Ampicillin 7 (9.7) 49 (25.1) 159 (48.0) 16 (12.2) 196 (26.0) 176 (11.2) 86 (23.4) 0.001
Cefoxitin 1 (1.4) 0 (0.0) 5 (1.5) 1 (0.80) 23 (3.0) 14 (0.9) 25 (6.8) 0.001
Ceftiofur 1 (1.4) 1 (0.5) 3 (0.9) 0 (0.0) 24 (3.2) 28 (1.8) 26 (7.1) 0.001
Ceftriaxone 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 2 (0.5) 0.177
Chloramphenicol 2 (1.5) 3 (1.5) 41 (12.4) 3 (2.3) 23 (3.0) 23 (3.0) 25 (6.8) 0.001
Ciprofloxacin 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 1 (0.1) 0 (0.0) 0.956
Gentamicin 0 (0.0) 1 (0.5) 0 (0.0) 0 (0.0) 9 (1.2) 13 (0.8) 32 (8.7) 0.001
Kanamycin 4 (5.6) 23 (11.8) 113 (34.1) 10 (7.6) 67 (8.9) 102 (6.5) 82 (22.3) 0.001
Nalidixic acid 0 (0.0) 1 (0.5) 0 (0.0) 0 (0.0) 0 (0.0) 3 (0.2) 0 (0.0) 0.001
Streptomycin 11 (15.3) 55 (28.2) 115 (34.7) 21 (16.0) 232 (30.7) 308 (19.5) 175 (47.5) 0.001
Sulfisoxazole 12 (16.7) 30 (15.4) 179 (54.1) 18 (13.7) 179 (23.7) 325 (20.6) 165 (44.8) 0.001
Tetracycline 46 (63.9) 176 (90.3) 325 (98.2) 107 (81.7) 622 (82.4) 1,310 (83.1) 335 (91.0) 0.001
Trimethoprim-
sulfamethoxazole
1 (1.4) 4 (2.0) 6 (1.8) 1 (0.8) 9 (1.2) 11 (0.7) 39 (1.1) 0.296
a Phenotypic resistance of commensal E. coli isolates among swine fecal sample (n  3,429 isolates with production groups identified). Frequencies are contrasted
by swine production groups across all unit locations and seasons.
b P values are based on a likelihood ratio chi-square test of the differences in risk between swine production groups. These P values are not adjusted for the
dependence of responses within unit locations.
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tomycin-tetracycline. Results were also cross-tabulated by con-
secutive seasons (winter, spring, summer, and autumn)
throughout the 3-year period (data not shown). In general,
high variability was observed among seasonal samples over the
3-year period for both human and swine isolates across all
units; however, no long-term trends (e.g., changes in preva-
lence over 3 years) were apparent.
Approximately 63% of the human E. coli isolates were pan-
susceptible to the 15 antimicrobial agents with the NARMS
panel, 18.6% were single-agent-resistant isolates, and 17.8%
were resistant to two or more antimicrobial agents. In contrast,
only 12.4% of the swine E. coli isolates were pansusceptible,
whereas 41.8% were single-agent-resistant isolates, and 45.7%
were resistant to two or more antimicrobial agents. The distri-
bution of multidrug-resistant E. coli phenotypes is not col-
lapsed into the 6 categories in Fig. 1 in order to better show
the maximum multidrug resistance phenotypes for E. coli iso-
lates arising from human and swine samples. The multidrug
resistance phenotypes for E. coli isolates were cross-tabulated
by season (winter, spring, summer, and autumn) across all 3
years and host species (Table 5). High variability was observed
among seasonal samples for the multidrug resistance pheno-
types over the 3-year period for both human and swine sam-
ples.
Multidrug resistance totals, cross-tabulated by human voca-
tion cohorts and swine production groups, are shown in Table
6. The multidrug-resistant E. coli isolates from human samples
differed significantly (i) among human vocation cohorts (2 
69.9; P 0.001) and (ii) among swine production groups (2
495.2; P  0.001) across all levels of multidrug resistance.
Multivariable analysis of risk factors for E. coli resistance to
individual antimicrobial agents. Comparison of E. coli resis-
tance to individual antimicrobial agents between host species.
The odds ratios and associated P values for E. coli resistance,
adjusted for the dependence of host species isolate response
within each unit location, comparing swine isolates to that of
humans, are shown in Table 2.
Comparison of E. coli resistance to individual antimicrobial
agents by swine production group. The odds ratios (ORs) for
E. coli resistance adjusted for the dependence of the swine
production group isolate response within each unit location
were significantly increased (P  0.05) for quarantined boar,
nursery piglet, and breeding boar E. coli isolates compared to
those of the swine referent group (slaughtered pigs) for tetracy-
cline (OR  12.25 [95% confidence interval {CI }, 2.41 to
62.15]; OR  3.50 [95% CI, 1.08 to 11.27]; and OR  3.20
[95% CI, 0.97 to 10.55], respectively) and streptomycin (OR 
2.90 [95% CI, 1.42 to 5.95]; OR  4.96 [95% CI, 2.46 to 9.99];
and OR  2.14 [95% CI, 1.02 to 4.50], respectively). Further-
more, the ORs of E. coli resistance adjusted for the depen-
dence of swine production group isolate response within each
unit location were significantly increased (P  0.05) for isola-
tion boar and nursery piglet E. coli isolates compared to those
of the swine referent group (slaughtered pigs) for sulfisoxazole
(OR  5.83 [95% CI, 3.01 to 11.34] and 4.06 [95% CI, 2.10 to
7.85], respectively). Table 4 provides the proportion of resis-
FIG. 1. Frequency bar chart illustrating the distribution of phenotypic resistance to up to 15 antimicrobials among E. coli isolates from human
and swine samples.
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tant E. coli isolates by swine production group for each anti-
microbial agent.
Comparison of E. coli resistance to individual antimicrobial
agents by human vocation cohort. The ORs for E. coli resis-
tance adjusted for the dependence of human vocation cohort
isolate response within each unit location were significantly
increased (P  0.05) among non-swine worker/nonconsumer
isolates for amoxicillin-clavulanic acid (OR  2.28 [95% CI,
1.38 to 3.77]), ampicillin (OR  1.83 [95% CI, 1.40 to 2.39]),
and cefoxitin (OR  2.25 [95% CI, 1.35 to 3.75]) compared to
those of non-swine workers. Furthermore, the ORs of E. coli
resistance adjusted for the dependence of human vocation
cohort E. coli isolate response within each unit location were
significantly increased (P  0.05) among slaughter plant
worker isolates for cefoxitin (OR  2.38 [95% CI, 1.10 to
5.17]) compared to those of non-swine workers. Moreover, the
ORs for E. coli resistance among swine workers adjusted for
the dependence of human vocation cohort isolate response
within each unit location were significantly lower (P 0.05) for
sulfisoxazole (OR  0.75 [95% CI, 0.59 to 0.95]) and cefoxitin
(OR  0.47 [95% CI, 0.25 to 0.88]) compared to those of
non-swine workers. The ORs for E. coli resistance, adjusted for
the dependence of human vocation cohort isolate response
within each unit location among pork consumer (i.e., swine
workers, non-swine workers, and slaughter plant workers) E.
coli isolates were significantly lower (P  0.05) for amoxicillin-
clavulanic acid (OR  0.42 [95% CI, 0.27 to 0.66]), ampicillin
(OR  0.53 [95% CI, 0.41 to 0.67]), cefoxitin (OR  0.37
[]95% CI, 0.23 to 0.59]), ciprofloxacin (OR  0.39 [95% CI,
0.16 to 0.92]), and kanamycin (OR  0.43 [95% CI, 0.22 to
0.86]) compared to those of the non-swine worker/noncon-
sumer group cohorts.
Comparison of E. coli resistance to individual antimicrobial
agents by season. There were small changes observed among
the seasonal isolates (i.e., overall seasons, collapsed by season
and year, and collapsed by season-by-year interaction) for both
human and swine isolates over the 3-year study period (data
not shown). However, no repeatable seasonal trend was de-
tected, nor was there a long-term trend showing change of
prevalence over the 3-year period. This conclusion was based
on the very high variability and instability in the GEE model
parameter estimates for each of the 15 antimicrobial resistance
outcomes for E. coli in relation to the seasons.
Multivariable analysis of risk factors for E. coli resistance to
multiple antimicrobial agents. Comparison of E. coli resis-
tance to multiple antimicrobial agents by host species. The
multinomial ORs for the total multidrug resistance phenotype
adjusted for the dependence of host species isolate response
within each unit location were significantly increased (P 
0.05) among swine isolates (OR  6.47 [95% CI, 4.29 to 9.76])
compared to those of human isolates across all levels of mul-
tidrug resistance.
Comparison of E. coli resistance to multiple antimicrobial
agents by swine production group. The multinomial ORs for
the total multidrug resistance phenotype adjusted for the de-
pendence of swine production group isolate response within
each unit location did not differ significantly (P  0.05) by
swine production group.
Comparison of E. coli resistance to multiple antimicrobial
agents by human vocation cohort. The multinomial ORs for
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total multidrug resistance adjusted for the dependence of hu-
man vocation cohort isolate response within each unit location
were significantly (P  0.05) increased among slaughter plant
worker isolates (OR  1.70 [95% CI, 1.44 to 1.90]) compared
to those of the referent (non-swine workers) isolates.
Comparison of E. coli resistance to multiple antimicrobial
agents by season. There were small changes observed among
the seasonal isolates (i.e., overall seasons, collapsed by season
and year, and collapsed by season-by-year interaction) for both
human and swine isolates over the 3-year study period (Table
7 shows the ORs of multidrug-resistant E. coli isolates by host
species and season). However, once again, no repeatable sea-
sonal trend was detected. Table 5 provides the proportion of
multidrug-resistant (1 to 6 categories) E. coli isolates by
season of human and swine isolates for each antimicrobial
agent.
Multivariate analysis of risk factors for E. coli resistance to
multiple outcomes: by host species. The multivariate ORs ad-
justed for multiple binary outcomes (i.e., multivariate individ-
ual phenotypes per isolate) were variable (that is, both in-
creased or decreased) relative to the unadjusted ORs among
swine isolates compared to those among human isolates (data
not shown).
Multivariate analysis by human cohorts and swine produc-
tion groups. Seven antimicrobial agents’ resistance outcomes
were excluded from the multivariate analysis model because
the GEE model failed to converge; that is, it failed to report
the parameter estimates with all 15 antimicrobial agents’ re-
sistance outcomes included in the dependent term for the
model. All of these antimicrobial agents’ resistance outcomes
were from rare resistance phenotypes with very sparsely pop-
ulated cells for some categories. Therefore, only eight antimi-
crobial agents’ resistance outcomes were included in the final
analysis (Table 8). The adjusted ORs of multiple binary out-
comes (i.e., multivariate phenotypes) were decreased and be-
came nonsignificant (P  0.05) relative to the unadjusted (for
multivariate outcomes) ORs among slaughter plant worker
isolates compared to non-swine workers isolates only for am-
picillin (OR  1.17 versus 1.04). The changes in adjusted ORs
relative to the unadjusted ORs (increased or decreased) were
variable among swine workers, slaughter plant worker, non-
swine worker/nonconsumer, and swine production group
isolates compared to that of non-swine workers (see the com-
parison in Table 8).
DISCUSSION
To our knowledge, the present study is the first that longi-
tudinally assesses the risk for the elevated prevalence of AR
bacteria in human populations in an integrated human and
swine system as a result of direct occupational exposure to
animals (i.e., swine).
TABLE 6. Multidrug resistance phenotypes of commensal E. coli isolates sampled across human vocation and swine production groupsa
Multidrug
resistance
response
No. of multidrug-resistant E. coli isolate (% of total) samples byb:
Human vocation group Swine production group
Non-swine
workers/
nonconsumers
(n  528)
Swine
workers
(n  1,131)
Non-swine
workers
(n  1,675)
Influent (mixed
isolates)
(n  252)
Slaughter
holding pigs
(n  307)
Breeding
boars
(n  195)
Quarantined
boars
(n  331)
Breeding/
gestation
females
(n  131)
Farrowing
sows and
piglets
(n  755)
Grower and
finisher pigs
(n  1,576)
Nursery
piglets
(n  368)
0 309 (58.52) 747 (66.05) 1,100 (65.67) 158 (62.70) 24 (33.33) 15 (7.69) 4 (1.21) 20 (15.27) 110 (14.57) 233 (14.78) 18 (4.89)
1 99 (18.75) 203 (17.95) 295 (17.61) 47 (18.65) 29 (40.28) 85 (43.59) 67 (20.24) 69 (52.67) 283 (37.48) 780 (49.49) 120 (32.61)
2 32 (6.06) 67 (5.92) 82 (4.90) 21 (8.33) 10 (13.89) 46 (23.59) 73 (22.05) 24 (18.32) 127 (16.82) 284 (18.02) 55 (14.95)
3 45 (8.52) 52 (4.60) 74 (4.42) 10 (3.97) 4 (5.56) 34 (17.44) 70 (21.15) 11 (8.40) 141 (18.68) 165 (10.47) 68 (18.48)
4 18 (3.41) 23 (2.03) 67 (4.00) 8 (3.17) 3 (4.17) 10 (5.13) 75 (22.66) 7 (5.34) 60 (7.95) 74 (4.70) 53 (14.40)
5 12.00 (2.27) 18 (1.59) 28 (1.67) 5 (1.98) 1 (1.39) 5 (2.56) 30 (9.06) 0 (0.00) 13 (1.72) 27 (1.71) 18 (4.89)
6c 13 (2.46) 21 (1.86) 29 (1.73) 3 (1.19) 1 (1.39) 0 (0.00) 12 (3.63) 0 (0.00) 21 (2.78) 13 (0.82) 36 (9.78)
a Multidrug resistance phenotypes of commensal E. coli isolates (n  7,477 overall sample isolates) from human and swine fecal isolates (human and swine cohorts).
Frequencies and percentages of multidrug-resistant E. coli isolates are presented and contrasted with those of human vocation cohorts and swine production cohorts.
Isolates are compared across all unit locations and seasons.
b Multidrug-resistant E. coli isolates from human samples differed significantly (2  69.9, P  0.001) among human vocation cohorts across all levels of multidrug
resistance, using m-by-n likelihood-ratio chi-square test. Likewise, the multidrug-resistant E. coli isolates from swine samples differed significantly (2  495.2, P 
0.001) among swine production groups across all levels of multidrug resistance. Both P values are not adjusted for the dependence of responses within unit locations.
c Multidrug resistance to greater than six antimicrobial agents (6) was collapsed into a single upper category.
TABLE 7. Multidrug resistance phenotypes of commensal E. coli isolates sampled by year and season over 3 yearsa
Host species
(n)
Odds ratio of resistant E. coli isolates sampled by year and season (P value)b
Spring 2004 Summer2004
Autumn
2004
Winter
2005
Spring
2005
Summer
2005
Autumn
2005
Winter
2006
Spring
2006
Summer
2006
Autumn
2006
Human (4,048) 1.05 (0.77) 1.01 (0.98) 0.97 (0.91) 1.86 (0.01) 0.41 (0.01) 0.80 (0.15) 0.85 (0.47) 0.42 (0.001) 1.17 (0.25) 1.49 (0.12) 0.92 (0.76)
Swine (3,429) 1.49 (0.001) 2.03 (0.12) 0.88 (0.62) 0.71 (0.04) 0.70 (0.02) 0.97 (0.75) 0.90 (0.42) 1.14 (0.66) 1.30 (0.02) 0.90 (0.62) 1.04 (0.93)
a Multidrug resistance phenotypes of commensal E. coli isolates from human wastewater and swine fecal samples. The odds ratios of multidrug-resistant E. coli
isolates are presented and contrasted by host species and season. Isolates are compared across all unit locations, human vocation cohorts, and swine production groups.
Odds ratios are presented comparing the odds of seasonal multidrug-resistant E. coli isolates to winter 2004 (the referent season). Multidrug resistance values greater
than 6 antimicrobial agents (6) were collapsed into a single upper-level category.
b Total n  7,477 overall sample isolates. P values are adjusted for the dependence of seasonal isolate responses within each unit location by using the generalized
estimating equation (GEE) statistic (PROC GENMOD; SAS Institute, Inc., Cary, NC). The overall chi-square statistic for the season was not significant for human
isolates (2  15.92, P  0.14), as well as for swine isolates (2  11.79, P  0.38).
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In our study, the higher levels of E. coli resistance in swine
isolates than in human isolates are likely associated with either
the past or current use of injectable antimicrobial agents (e.g.,
ceftiofur sodium) or the use of antimicrobial agents in feed
(e.g., chlortetracycline) or water on a larger scale than that
used in human medicine. On the other hand, human isolates
had higher levels of resistance than swine isolates to five indi-
vidual antimicrobial agents (ciprofloxacin, trimethoprim-sulfa-
methoxazole, nalidixic acid, cefoxitin, and amoxicillin-clavu-
lanic acid), which might be explained by the use of these agents
mainly in human medicine and rarely, if ever, in the swine
industry (especially in our study population). We have ongoing
analyses to evaluate the relationship between AR levels and
the recent and concurrent use of antimicrobial agents in both
host species. However, there are no data concerning longer-
range historical use of the antimicrobial agents in these two
populations. The historical use of the antimicrobial agents, in
the relatively short time frame of the study, is only one com-
ponent of the risk factors and is not the focus of the present
paper. Short-term fluctuations in antimicrobial use may well be
predictive of the short-term AR fluctuations in relatively newly
introduced drugs but do not tend to explain macro trends in
AR within swine, as evidenced by the small reductions in re-
sistance seen with organic versus conventional swine opera-
tions in the United States. (6).
Swine fecal E. coli isolates exhibiting multidrug resistance
were present at higher levels than human isolates. The higher
levels of multidrug resistance in the swine population than in
the human population might be attributed to several factors:
(i) the prophylactic/subtherapeutic use of several antimicrobial
agents in feed at the swine farms and (ii) the intensive farm
management practices on swine farms that may facilitate the
transmission, propagation, and maintenance of the AR bacte-
rial populations in both the swine hosts and the farm environ-
ment.
The adjusted ORs of resistance were significantly increased
among non-swine worker/nonconsumer isolates for amoxicil-
lin-clavulanic acid, ampicillin, and cefoxitin compared to those
of non-swine workers. The non-swine workers/nonconsumers
represented a negative control group that resided outside of
the agri-food study system. Therefore, these AR levels may
better reflect the resistance levels in the general population
compared to those in our within-system human populations.
The non-swine worker/nonconsumer group was an open pop-
ulation in which there was (i) limited or no control over the in-
and out-migration of humans; (ii) limited or no control over
human travel and trade (animals and food products), which
serve as a source for AR bacteria that can be introduced into
this population; and (iii) limited or no control over food con-
sumption from unknown sources. However, this cohort was
located near the other two populations.
The adjusted ORs of resistance were significantly increased
among slaughter plant worker isolates for cefoxitin compared
to those of non-swine workers (the referent group). Further-
more, the adjusted ORs of multidrug resistance were signifi-
cantly increased among slaughter plant worker isolates com-
pared to those of the non-swine workers. This might be
attributed to the overall high resistance prevalence in the
slaughtered pigs and the greater likelihood of slaughter work-
ers’ exposure to slaughtered pigs’ fecal matter, pigs’ skin con-
T
A
B
L
E
8.
M
ultivariate
resistance
phenotypes
of
com
m
ensal
E
.coliisolates
sam
pled
across
hum
an
vocation
groups
and
sw
ine
production
groups
a
A
ntim
icrobial
agent
A
djusted
for
dependence
am
ong
binary
outcom
es b
O
R
s
of
m
ultivariate
resistance
E
.coliphenotypes
(95%
C
I)
H
um
an
vocation
group
Sw
ine
production
group
Sw
ine
w
orker
isolates
N
on-sw
ine
w
orkers/
nonconsum
ers
Slaughter
plant
w
orkers
Q
uarantined
boars
B
reeding
boars
F
arrow
ing
sow
s
and
piglets
B
reeding/gestation
fem
ales
G
row
er
and
finisher
pigs
N
ursery
piglets
A
m
oxicillin-
clavulanic
acid
N
o
0.8
(0.53–1.20)
2.34
(1.60–3.41)
1.69
(1.24–2.28)
0.79
(0.60–1.05)
0.2
(0.03–1.37)
1.63
(0.77–3.48)
0.32
(0.06–1.80)
0.32
(0.21–0.50)
2.91
(0.77–11.00)
Y
es
0.73
(0.47–1.13)
2.13
(1.57–2.88)
1.41
(1.08–1.83)
0.98
(0.77–1.24)
0.13
(0.01–2.13)
1.3
(0.66–2.60)
0.23
(0.02–2.35)
0.32
(0.21–0.48)
2.4
(0.62–9.60)
A
m
picillin
N
o
0.86
(0.64–1.14)
1.74
(1.44–2.09)
1.17
(1.04–1.33)
6.35
(5.72–7.05)
1.70
(1.10–2.64)
1.80
(1.42–2.24)
0.72
(0.43–1.22)
0.71
(0.56–0.90)
1.56
(1.02–2.37)
Y
es
0.87
(0.66–1.16)
1.93
(1.57–2.37)
1.04
(0.90–1.19)
5.76
(5.00–6.62)
1.80
(1.17–2.69)
1.85
(1.43–2.39)
0.74
(0.43–1.30)
0.72
(0.56–0.92)
1.62
(1.07–2.44)
C
hloram
phenicol
N
o
1.48
(0.85–2.57)
1.58
(0.78–3.18)
0.36
(0.27–0.49)
9.11
(5.90–14.10)
0.69
(0.07–6.66)
1.50
(0.46–4.97)
1.24
(0.27–5.57)
1.92
(0.85–4.36)
3.94
(1.16–13.32)
Y
es
1.20
(0.66–2.18)
0.94
(0.31–2.86)
0.31
(0.20–0.47)
9.15
(5.88–14.23)
0.69
(0.11–4.36)
1.47
(0.52–4.15)
1.16
(0.29–4.62)
1.95
(0.94–4.05)
3.67
(1.18–11.39)
K
anam
ycin
N
o
0.77
(0.38–1.56)
2.04
(1.21–3.44)
2.26
(1.53–3.34)
38.69
(25.72–58.20)
10.71
(6.11–18.78)
7.88
(4.26–14.58)
6.59
(2.93–14.80)
5.75
(3.57–9.26)
22.41
(7.98–62.95)
Y
es
0.79
(0.41–1.53)
2.29
(1.52–3.45)
2.58
(1.81–3.69)
42.90
(29.46–62.49)
9.13
(5.02–16.61)
6.54
(3.63–11.79)
5.77
(2.38–13.99)
5.30
(3.29–8.39)
20.12
(6.65–60.84)
Streptom
ycin
N
o
1.02
(0.68–1.54)
1.20
(0.77–1.87)
1.49
(1.25–1.76)
5.88
(4.96–6.96)
4.15
(2.94–5.86)
4.69
(3.71–5.93)
2.03
(1.27–3.23)
2.59
(2.06–3.25)
9.59
(6.59–13.95)
Y
es
1.01
(0.67–1.52)
1.20
(0.86–1.68)
1.42
(1.23–1.63)
6.16
(5.27–7.19)
3.85
(2.87–5.16)
4.34
(3.53–5.34)
1.90
(1.22–2.96)
2.56
(2.06–3.19)
8.99
(6.12–13.21)
Sulfisoxazole
N
o
0.72
(0.58–0.90)
0.91
(0.60–1.38)
1.00
(0.85–1.17)
7.77
(6.60–9.15)
1.14
(0.64–2.01)
1.95
(1.53–2.47)
1.01
(0.66–1.53)
1.68
(1.29–2.17)
5.12
(3.39–7.74)
Y
es
0.70
(0.57–0.86)
0.90
(0.65–1.24)
0.96
(0.83–1.10)
8.13
(6.89–9.59)
1.05
(0.56–1.96)
1.81
(1.45–2.27)
0.95
(0.61–1.46)
1.64
(1.28–2.11)
4.83
(3.20–7.28)
T
etracycline
N
o
1.1
(0.85–1.42)
0.99
(0.67–1.48)
1.68
(1.50–1.88)
256.73
(167.30–393.98)
25.71
(14.11–46.86)
14.15
(10.59–18.20)
14.53
(9.39–22.48)
20.71
(13.76–31.19)
28.11
(18.92–41.76)
Y
es
1.14
(0.90–1.43)
1.01
(0.71–1.43)
2.15
(1.81–2.56)
344.35
(281.05–421.91)
37.34
(16.94–82.28)
19.22
(12.97–28.47)
18.94
(11.46–31.29)
22.14
(14.33–34.21)
41.16
(25.45–66.55)
T
rim
ethoprim
-
sulfam
ethoxazole
N
o
0.86
(0.56–1.32)
1.17
(0.77–1.80)
1.52
(1.27–1.82)
0.28
(0.24–0.33)
0.26
(0.05–1.37)
0.15
(0.06–0.37)
0.10
(0.01–0.62)
0.09
(0.06–0.14)
0.24
(0.12–0.49)
Y
es
0.83
(0.55–1.24)
1.09
(0.78–1.53)
1.37
(1.17–1.60)
0.31
(0.25–0.39)
0.20
(0.02–1.69)
0.11
(0.03–0.40)
0.07
(0.01–0.57)
0.09
(0.05–0.14)
0.19
(0.07–0.50)
a
M
ultivariate
resistance
phenotypes
of
com
m
ensalE
.coliisolates
from
hum
an
w
astew
ater
and
sw
ine
fecalsam
ples.O
dds
ratios
(O
R
s)
and
95%
confidence
intervals
(C
I)
of
E
.coliisolates
are
presented
in
contrast
to
those
of
host
species
and
hum
an
vocation
and
sw
ine
production
groups.Isolates
are
com
pared
across
allunit
locations
and
seasons.
b
A
djustm
entfor
dependence
am
ong
m
ultivariate
resistance
phenotypes
(m
ultiple
binary
outcom
es)
w
ithin
each
unitlocation
w
as
conducted
by
a
G
E
E
statistic
in
a
univariate
and
m
ultivariate
m
odelusing
a
SA
S
m
acro
(SA
S
PR
O
C
G
E
N
M
O
D
;SA
S
Institute,Inc.,C
ary,N
C
).
VOL. 74, 2008 ANTIMICROBIAL RESISTANCE FROM HUMAN AND SWINE E. COLI 3679
 o
n
 Septem
ber 11, 2018 by guest
http://aem
.asm
.org/
D
ow
nloaded from
 
taminated with feces, and the gut contents of the killed pigs
that contain higher levels of AR bacteria than those of the
non-swine workers and swine workers. Nijsten et al. (12) re-
ported no significant differences between the levels of resis-
tance among the E. coli isolates of abattoir workers with or
without direct contact with pig fecal contents or pig carcasses.
The adjusted ORs of resistance among pork consumer E.
coli isolates were lower for five antimicrobial agents than those
of the non-swine worker/nonconsumer group. In general, the
consumption of food (e.g., pork) from unknown sources may
have increased the risk of AR bacteria in the “negative” con-
trol group compared that of the pork consumers within the
study system (the imported pork trim had a very low E. coli
prevalence [7.5%]). In addition, there may be differences, al-
beit unknown to the researchers, in the antibiotic consumption
patterns in this population.
In general, the isolation (i.e., purchased) boars showed
higher levels of resistance than swine-rearing and slaughtered
pigs for ampicillin, chloramphenicol, kanamycin, sulfisoxazole,
and tetracycline. In contrast, nursery piglets showed higher
levels of resistance than quarantined boars, other swine-rear-
ing, and slaughtered pigs for cefoxitin, ceftiofur, gentamicin,
and streptomycin. The quarantined (purchased) boars’ higher
resistance levels may be attributed to unknown but likely
higher historical antimicrobial use within the outside purebred
multiplier units. Furthermore, in our study population, nursery
piglets received larger amounts of injectable antimicrobial
agents than did the other swine production groups (data not
shown).
In our study, imported pork trim samples had very low levels
of AR E. coli isolates (7.5%), suggesting that a very small
proportion of resistant bacteria was likely introduced to the
system from the outside, through imported pork. Moreover, all
of this trim was processed into breakfast sausage before it was
shipped into the system. To the best of our knowledge, there
are no comparable literature data for AR E. coli levels in pork
trim or pork fat.
There was a high seasonal variability, without an apparent
seasonal trend, observed among swine and human samples
over the 3-year period, for both the individual antimicrobial
agent resistance and the multidrug resistance phenotypes. We
attempted a time-series analysis to determine the seasonal
trend in our longitudinal data. The time-series models did not
fit the data well, and that is likely because (i) our data were
binary in nature, which made it difficult to analyze using time-
series models (time-series models best explain the trends as-
sociated with time for continuous data); and (ii) our longitu-
dinal data structure consisted of multiple E. coli bacteria
isolated from multiple locations within each unit, measured
repeatedly at each time point (season). On the other hand, we
have ongoing analyses to determine whether the likely source
of the seasonal variability is attributable to seasonal differences
in historical and concurrent antimicrobial use in swine and
human populations or to other risk factors related to manage-
ment and selective bacterial survival at different times of the
year.
We assessed the mean number of E. coli colonies exhibiting
distinctly different resistance phenotypes in samples collected
during a single month (February 2005) for both host species.
Based on an expected median of just two distinct phenotypes
and comparisons to that in the literature, e.g., Berge et al. (5)
reported a mean of 1.8 phenotypes per five E. coli colonies
from dairy calf fecal samples, with a total of 5,366 isolates
evaluated, the additional resources out of a finite budget con-
sumed by evaluating phenotypes for 5 isolates per sample in-
stead of one, and our much greater interest in assessing resis-
tance levels longitudinally over the 3-year period, we elected
instead to assess 1 isolate per sample to test for antimicrobial
susceptibility. This ensured statistically that there was no
within-sample monthly clustering of results, especially consid-
ering the very high intracluster correlation on each plate.
Semiquantitative results (i.e., MICs) are important in order
to monitor small shifts in susceptibility and resistance at the
population level. However, the MIC data with 2-fold differ-
ences in antibiotic concentration per dilution are difficult to
analyze statistically and interpret in multivariable models;
there were inconsistent numbers of dilution across the 15 an-
timicrobial agents, and these differences were truly not the
subject of this study.
We enriched our human wastewater samples prior to plat-
ing, whereas we did not do so for swine feces. The only way in
which enrichment of the human wastewater samples and not
the swine fecal samples could potentially cause a differential
misclassification bias is if resistant (or susceptible) strains of E.
coli were favored by the enrichment step contained within the
wastewater process, but not the swine fecal culture process.
The enrichment step for wastewater samples could potentially
have changed the composition of resistant and susceptible E.
coli isolates from wastewater samples and therefore the sample
from the enrichment broth that was then plated on the
CHROMagar. For example, (i) E. coli bacteria might have
shed resistance plasmids in the enrichment broth, which would
have resulted in an underestimation of the levels of resistance
compared to that of the raw wastewater sample; (ii) in a com-
petitive broth (such as the enrichment step), less-fit resistant
bacteria may grow slower than susceptible bacteria, hence de-
creasing the probability of plating and selecting a resistant
isolate. These arguments are, in part, based on published re-
sults from in vitro noncompetitive and competitive studies.
However, it is possible that many other factors affect bacterial
growth and competition in a competitive culture (the enrich-
ment step) and possibly result in an increased probability of
selecting a resistant E. coli isolate, or have no effect at all. In
other words, it is impossible to determine the direction of the
bias associated with the enrichment step. Hence, in this study,
the measures of association may be biased away from or to-
ward the null; that is, the measure of association may be either
over- or underestimated when outcomes from swine are com-
pared with those of human populations.
Adjusting for the dependence in the multiple binary out-
comes (i.e., multivariate phenotypes) using the SAS macro had
a variable effect on the OR values (i.e., ranging from 3 to 28%
increase or decrease) and their CIs compared to that of unad-
justed ORs and their CIs. In general, there was not a dramatic
change in the OR direction of effect (e.g., 1 to 1 or vice
versa) when adjusted for multiple binary outcomes. However,
the CI for slaughter plant workers included 1 (null value) when
adjusted for multiple binary outcomes, indicating that the OR
for ampicillin resistance became statistically nonsignificant af-
ter the adjustment compared to that of non-swine workers.
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There are few or no published works that adjust for the de-
pendence among multiple binary AR outcome data. This is
clearly important, especially since several of the antimicrobial
agents on the NARMS panels arise from the same class of
drugs; that is, we would expect that there should be biological
dependence (both pharmacologic effect, as well as genetic link-
ages in the bacteria) that must be accounted for.
In conclusion, this is the first major longitudinal study con-
ducted to assess the risk of carriage of AR bacteria due to
human occupational and consumption exposure to swine in a
multisite, vertically integrated agri-food system. The study de-
sign and sample collection strategy complements the existing
related AR research that has addressed the risk of resistant
bacterial transmission to humans as a result of direct contact
with animals. In this longitudinal study (over the 3-year pe-
riod), occupational exposure of the slaughter plant workers to
bacteria appeared to be associated with higher cefoxitin resis-
tance and multidrug resistance than that of non-swine workers.
The highest E. coli resistance prevalence for tetracycline was
observed with slaughter plant workers compared to that of the
other human vocation cohorts, though the differences were of
marginal statistical significance. This finding might be attrib-
uted to the higher occupational exposure of slaughter plant
workers to AR bacteria than that of non-swine workers. In
general, (i) the swine E. coli isolates across all units had higher
levels of resistance than those of humans, and (ii) the swine
production group-resistant isolates differed significantly, with
the highest levels found in purchased boars, breeding boars,
and nursery piglets. Adjusting for the dependence within mul-
tivariate phenotypes, using the multivariate model of corre-
lated dependence had variable effects on the ORs and their CIs
before adjustment. Seasonal effect was highly variable over the
3-year study period. An ongoing analysis is being conducted to
evaluate the relationship between AR seasonal variability and
the recent and concurrent use of antimicrobial agents in both
host species.
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